Estimated Benefit of Dose Reduction to Highly Ventilated Lung Regions for Stage III Non–small Cell Lung Cancer Patients Using Normal Tissue Complication Probability Models

Small Cell ◽

Small Cell Lung ◽

Probability Models ◽

The use of real-world evidence to audit normal tissue complication probability models for acute esophageal toxicity in non-small cell lung cancer patients

10.1016/j.radonc.2020.02.006 ◽

2020 ◽

Vol 146 ◽

pp. 52-57

Author(s):

Margriet H. Kwint ◽

Iris Walraven ◽

Marcel Verheij ◽

Jan-Jakob Sonke ◽

José S.A. Belderbos ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Real World ◽

Normal Tissue ◽

Small Cell ◽

Small Cell Lung ◽

Probability Models ◽

Lung Cancer Patients ◽

Real World Evidence

Efficacy of tyrosine kinase inhibitors in non-small-cell lung cancer patients undergoing dose reduction and those with a low body surface area

Molecular and Clinical Oncology ◽

10.3892/mco.2014.281 ◽

2014 ◽

Vol 2 (4) ◽

pp. 604-608 ◽

Cited By ~ 10

Author(s):

SHINYA SATO ◽

KOICHI KURISHIMA ◽

KUNIHIKO MIYAZAKI ◽

TAKAHIDE KODAMA ◽

HIROICHI ISHIKAWA ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Dose Reduction ◽

Cancer Patients ◽

Body Surface ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy

10.1016/j.radonc.2015.08.010 ◽

2015 ◽

Vol 117 (1) ◽

pp. 49-54 ◽

Cited By ~ 30

Author(s):

Robin Wijsman ◽

Frank Dankers ◽

Esther G.C. Troost ◽

Aswin L. Hoffmann ◽

Erik H.F.M. van der Heijden ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Normal Tissue ◽

Small Cell ◽

Advanced Stage ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Intensity Modulated

Lyman–Kutcher–Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy

10.1016/j.radonc.2020.03.003 ◽

2020 ◽

Vol 146 ◽

pp. 200-204 ◽

Cited By ~ 1

Author(s):

Zeming Wang ◽

Mei Chen ◽

Jian Sun ◽

Shengpeng Jiang ◽

Li Wang ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Normal Tissue ◽

Small Cell ◽

Proton Radiotherapy ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Probability Modeling ◽

Radiation Induced

Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models

10.1016/j.radonc.2019.05.011 ◽

2019 ◽

Vol 138 ◽

pp. 45-51 ◽

Cited By ~ 10

Author(s):

M. Thor ◽

Jo Deasy ◽

A. Iyer ◽

E. Bendau ◽

A. Fontanella ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Normal Tissue ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Probability Models

Pembrolizumab in the non-small-cell lung cancer patients – reasons to consider its use

Oncoreview ◽

10.24292/01.or.141217 ◽

2017 ◽

Vol 7 (4) ◽

pp. 199-202

Author(s):

Magdalena Knetki-Wróblewska

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

Case Medical Research ◽

10.31525/ct1-nct03866499 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

Case Medical Research ◽

10.31525/ct1-nct04253964 ◽

2020 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Pilot Study ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Small Cell Lung ◽

Faculty Opinions recommendation of Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725853745.793510697 ◽

2015 ◽

Author(s):

Alexandru Grigorescu

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Consolidation Therapy ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Faculty Opinions recommendation of Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9003.466776 ◽

2006 ◽

Author(s):

Martine Extermann

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Small Cell ◽

Small Cell Lung ◽

North Central ◽

Lung Cancer Patients ◽

The North